Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Beibei Guo

Showing results (11-20 of 150) with videos related to

Pageof 15
Sort By:
Biostatistics and Biometrics Open Access Journal|April 13, 2018
Statistical Methods for Clinical Trial Designs in the New Era of Cancer TreatmentBeibei Guo, Rui Zhang
Biometrics|February 22, 2023
DROID: dose-ranging approach to optimizing dose in oncology drug developmentBeibei Guo, Ying Yuan
Statistics in Medicine|November 25, 2021
BIPSE: A biomarker-based phase I/II design for immunotherapy trials with progression-free survival endpointBeibei Guo, Yong Zang
BMC Medical Research Methodology|July 31, 2014
Bayesian designs of phase II oncology trials to select maximum effective dose assuming monotonic dose-response relationshipBeibei Guo, Yisheng Li
Statistical Methods in Medical Research|November 29, 2015
Optimal two-stage enrichment design correcting for biomarker misclassificationYong Zang, Beibei Guo
Journal of the American Statistical Association|November 20, 2019
A Bayesian Phase I/II Trial Design for ImmunotherapySuyu Liu, Beibei Guo, Ying Yuan
Statistics in Medicine|January 23, 2026
A Biomarker-Based Dose-Schedule Optimization Design for Immunotherapy TrialsYingjie Qiu, Yan Han, Beibei Guo
Statistics in Biopharmaceutical Research|August 26, 2024
Treatment Comparisons in Adaptive Platform Trials Adjusting for Temporal DriftBeibei Guo, Li Wang, Ying Yuan
Journal of the Royal Statistical Society. Series C, Applied Statistics|February 16, 2016
A dose-schedule finding design for phase I-II clinical trialsBeibei Guo, Yisheng Li, Ying Yuan
Medicine|March 15, 2024
Idiopathic mesenteric phlebosclerosis occurring in a patient with liver cirrhosis: A case reportCongjie Zhang, Haijun Huang, Beibei Guo
Pageof 15

Showing results (11-20 of 150) with videos related to

Sort By:
Pageof 15
Biostatistics and Biometrics Open Access Journal|April 13, 2018
Statistical Methods for Clinical Trial Designs in the New Era of Cancer TreatmentBeibei Guo, Rui Zhang
Biometrics|February 22, 2023
DROID: dose-ranging approach to optimizing dose in oncology drug developmentBeibei Guo, Ying Yuan
Statistics in Medicine|November 25, 2021
BIPSE: A biomarker-based phase I/II design for immunotherapy trials with progression-free survival endpointBeibei Guo, Yong Zang
BMC Medical Research Methodology|July 31, 2014
Bayesian designs of phase II oncology trials to select maximum effective dose assuming monotonic dose-response relationshipBeibei Guo, Yisheng Li
Statistical Methods in Medical Research|November 29, 2015
Optimal two-stage enrichment design correcting for biomarker misclassificationYong Zang, Beibei Guo
Journal of the American Statistical Association|November 20, 2019
A Bayesian Phase I/II Trial Design for ImmunotherapySuyu Liu, Beibei Guo, Ying Yuan
Statistics in Medicine|January 23, 2026
A Biomarker-Based Dose-Schedule Optimization Design for Immunotherapy TrialsYingjie Qiu, Yan Han, Beibei Guo
Statistics in Biopharmaceutical Research|August 26, 2024
Treatment Comparisons in Adaptive Platform Trials Adjusting for Temporal DriftBeibei Guo, Li Wang, Ying Yuan
Journal of the Royal Statistical Society. Series C, Applied Statistics|February 16, 2016
A dose-schedule finding design for phase I-II clinical trialsBeibei Guo, Yisheng Li, Ying Yuan
Medicine|March 15, 2024
Idiopathic mesenteric phlebosclerosis occurring in a patient with liver cirrhosis: A case reportCongjie Zhang, Haijun Huang, Beibei Guo
Pageof 15